Phase 3 DeLLphi-305 results show that adding tarlatamab to durvalumab as first-line maintenance therapy extended median ...

What Is Stage III Lung Cancer? Doctors use stages to describe how much cancer you have and where it is in your body. People with stage III lung cancer can be a very mixed group. Their tumors can ...

Adding Imdelltra (tarlatamab) to Imfinzi (durvalumab) maintenance therapy helped people with extensive-stage small cell lung ...

In patients with extensive-stage small cell lung cancer (ES-SCLC), tarlatamab, a bispecific T-cell engager, plus durvalumab ...

Tarlatamab plus durvalumab extended median survival from 12.7 to 21.1 months in small-cell lung cancer patients in the phase ...